why choose us

First received: April 19, 2023

Clinical Trial: Low Sodium Oxybate in Patients With Idiopathic Hypersomnia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Idiopathic Hypersomnia

Study Type: INTERVENTIONAL


Official Title: Impact of Low Sodium Oxybate on Total Sleep Time in Patients With Idiopathic Hypersomnia

Brief Summary: Low sodium oxybate has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic hypersomnia.In this study, the researchers want to learn how low sodium oxybate impacts ability of people diagnosed with idiopathic hypersomnia to sleep for long periods of time.In addition, this study will use novel tools to determine when an individual is awake or asleep.

Read more